IO BIOTECH INC's ticker is and the CUSIP is 449778109. A total of 18 filers reported holding IO BIOTECH INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,103,364 | +26.4% | 5,747,067 | +75.3% | 0.60% | +21.0% |
| Q2 2023 | $6,408,357 | +4.3% | 3,277,932 | 0.0% | 0.50% | +21.9% |
| Q1 2023 | $6,146,123 | -18.5% | 3,277,932 | 0.0% | 0.41% | -13.8% |
| Q4 2022 | $7,539,244 | -15.1% | 3,277,932 | 0.0% | 0.47% | +11.1% |
| Q3 2022 | $8,883,000 | -42.0% | 3,277,932 | 0.0% | 0.42% | -43.8% |
| Q2 2022 | $15,308,000 | -11.9% | 3,277,932 | 0.0% | 0.75% | -17.7% |
| Q1 2022 | $17,373,000 | -17.2% | 3,277,932 | 0.0% | 0.92% | -7.8% |
| Q4 2021 | $20,979,000 | – | 3,277,932 | – | 0.99% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vivo Capital, LLC | 3,015,545 | $6,936 | 0.80% |
| Samsara BioCapital, LLC | 1,008,437 | $2,319,405 | 0.50% |
| Novo Holdings A/S | 3,277,932 | $7,539,244 | 0.47% |
| Avoro Capital Advisors LLC | 2,055,883 | $4,728,531 | 0.07% |
| RA Capital Management | 1,127,260 | $2,592,698 | 0.05% |
| Newtyn Management, LLC | 90,000 | $207,000 | 0.04% |
| PFM Health Sciences, LP | 507,640 | $1,167,572 | 0.04% |
| Psagot Value Holdings Ltd. / (Israel) | 40,846 | $94 | 0.03% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 132,200 | $304,060 | 0.01% |
| Cannell Capital | 12,594 | $28,966 | 0.01% |